Pharmaceutical Products In Development

NanaBisTM

Status: In clinical Trial

Purpose:  Adjuvant and/or replacement therapy to opioids in advanced cancer pain

Descriptive:  Nanocelle delivery platform (buccal spray)

Proposed Regulatory Pathway: Australian S8 Specialist led.

NanaBidialTM

Status: In clinical trial

Purpose: For CINV and seizures

Descriptive:  Nanocelle delivery platform (buccal spray)

Proposed Regulatory Pathway: Australian S4 , GP led

NanoStatTM

Status: In clinical Trial

Purpose: For the treament of elevated cholestrol

Descriptive:  Nanocelle delivery platform (buccal spray)

Proposed Regulatory Pathway: Australian S4 , GP led

NanUlinTM

Status: HREC aaproved trial forthcoming

Purpose: For type 2 diabetics

Descriptive:  Nanocelle delivery platform (buccal spray)

Proposed Regulatory Pathway: Australian S4 , GP led

NanoTestTM

Status: HREC approval trial forthcoming

Purpose: For increasing low testosterone levels in men

Descriptive:  Nanocelle delivery platform (buccal spray)

Proposed Regulatory Pathway: Australian S4 , GP led

NanoCelle FexodenadineTM

Status: In trial development

Purpose: Fast absorption Antihistamine

Descriptive: Nanocelle delivery platform (buccal spray)

Proposed Regulatory Pathway: Australian S4 , GP led

NRGBioticTM

Status: In clinical trial [Phase 2]

Purpose: For TD patients on SSRI's

Descriptive: Probiotic formula combined with Coenzyme Q10 and Magnesium Orotate.

Proposed Regulatory Pathway:  Listed medicine, GP led

ORSBioticTM

Status: In trial development

Purpose: Provides essential electrolytes to replace fluids lost due to vomiting, diarrhoea and strenuous physical activity

Descriptive: Oral Rehydration Solution

Proposed Regulatory Pathway: Listed medicine, GP led

T2BioticTM

Status: Clinical trial concluded, product listed

Purpose: For treatment of pre-diabetic patients

Descriptive: Multi-species, multi-strain probiotic

Proposed Regulatory Pathway: Listed medicine , GP led

MultiBioticTM

Status: In trial development

Purpose: For the treament of chemotherapy induced diarrhoea

Descriptive: Multi-species, multi-strain probiotic

Proposed Regulatory Pathway: Listed medicine, GP led